The BK polyomavirus often causes complications after kidney transplantation. The research group of Professor Hans H. Hirsch from the Department of Biomedicine at the University of Basel has now been able to show, that the immunosuppressive drug Tacrolimus directly activates the replication of the virus and could thus be responsible for these complications. The “American Journal of Transplantation” has published the study.
Polyomavirus infections are common, however, they usually do not cause symptoms in healthy adults. However, the virus becomes much more problematic for patients who have to take immunosuppressive drugs after kidney transplantation.
The authors of the research group Transplantation & Clinical Virology with Hans H. Hirsch, Min Lu, Julia Manzetti and Ksenia Yakhontova (from left). © University of Basel
In ten to twenty percent of all cases, the BK virus starts to spread within the transplant and causes an inflammation. This can, in the worst case, destroy the new organ entirely and put the patient back on the transplant waiting list.
When it comes to organ transplantation, doctors mainly fight the human immune system, which tries to reject the donor organ. Immunosuppressive drugs, such as the commonly used Tacrolimus, are prescribed to suppress this process.
The substance inhibits signaling between the body's immune cells. However, this treatment also weakens the immune system in such a way that it is no longer able to protect the organism sufficiently from viruses such as said BK virus – a predicament.
Drugs affect virus differently
The Transplantation & Clinical Virology research group from the Department of Biomedicine at the University of Basel led by Professor Hans H. Hirsch was now able to show, that the BK virus reacts completely different to various immunosuppressive drugs: While the commonly used drug Tacrolimus activates the replication of the virus inside kidney cells, the substance Sirolimus, a mTOR inhibitor, inhibits virus replication.
The results explain why in the past ten years an increasing number of cases of BK polyomavirus complications have occurred after the widespread introduction of Tacrolimus in transplantation clinics. The findings also provide important rationales for clinical trials in order to test the use of mTOR inhibitors like Sirolimus in patients in acute danger of loosing their kidney transplant without simultaneously having to increase the risk of organ rejection.
H. H. Hirsch, K. Yakhontova, M. Li and J. Manzetti
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12
American Journal of Transplantation 2015; XX: 1–12 | doi: 10.1111/ajt.13541
Hans H. Hirsch, University of Basel Basel, Department of Biomedicine, phone: +41 (0)61 267 32 25, email: email@example.com
Olivia Poisson | Universität Basel
Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute
Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy